Your browser is no longer supported. Please, upgrade your browser.
GILD [NASD]
Gilead Sciences, Inc.
IndexS&P 500 P/E333.25 EPS (ttm)0.21 Insider Own0.10% Shs Outstand1.26B Perf Week0.51%
Market Cap85.69B Forward P/E10.32 EPS next Y6.65 Insider Trans-4.27% Shs Float1.25B Perf Month2.39%
Income301.00M PEG238.04 EPS next Q1.73 Inst Own80.50% Short Float1.93% Perf Quarter4.59%
Sales25.56B P/S3.35 EPS this Y-97.70% Inst Trans0.23% Short Ratio3.53 Perf Half Y2.49%
Book/sh15.09 P/B4.55 EPS next Y-5.90% ROA0.50% Target Price74.61 Perf Year-9.97%
Cash/sh4.54 P/C15.12 EPS next 5Y1.40% ROE1.70% 52W Range56.56 - 76.80 Perf YTD17.83%
Dividend2.84 P/FCF16.46 EPS past 5Y-61.80% ROI5.00% 52W High-10.13% Beta0.41
Dividend %4.14% Quick Ratio1.20 Sales past 5Y-5.40% Gross Margin80.60% 52W Low22.03% ATR1.04
Employees13600 Current Ratio1.40 Sales Q/Q15.80% Oper. Margin17.80% RSI (14)57.30 Volatility1.62% 1.44%
OptionableYes Debt/Eq1.59 EPS Q/Q12.20% Profit Margin1.20% Rel Volume0.49 Prev Close68.65
ShortableYes LT Debt/Eq1.47 EarningsJul 29 AMC Payout- Avg Volume6.87M Price69.02
Recom2.40 SMA201.05% SMA501.71% SMA2007.51% Volume3,399,206 Change0.54%
Apr-01-21Upgrade Bernstein Mkt Perform → Outperform $80
Mar-30-21Upgrade Redburn Neutral → Buy
Jan-19-21Upgrade Morgan Stanley Equal-Weight → Overweight $83
Jan-04-21Upgrade Guggenheim Neutral → Buy
Nov-03-20Resumed Morgan Stanley Equal-Weight $67
Oct-28-20Initiated UBS Neutral $61
Sep-30-20Resumed Jefferies Buy $78
Sep-15-20Upgrade Maxim Group Hold → Buy $88
Jul-31-20Reiterated Wells Fargo Equal Weight $87 → $76
Jul-31-20Reiterated SunTrust Hold $73 → $74
Jul-31-20Reiterated RBC Capital Mkts Outperform $89 → $87
Jul-31-20Reiterated Piper Sandler Overweight $90 → $85
Jul-31-20Reiterated Morgan Stanley Equal-Weight $80 → $79
Jul-31-20Reiterated Credit Suisse Neutral $75 → $73
Jul-20-20Upgrade Credit Suisse Underperform → Neutral $64 → $75
Jun-03-20Upgrade SVB Leerink Mkt Perform → Outperform $85 → $94
May-26-20Upgrade SunTrust Sell → Hold $73
May-01-20Downgrade SunTrust Hold → Sell $70
May-01-20Downgrade Raymond James Outperform → Mkt Perform
May-01-20Downgrade JP Morgan Overweight → Neutral
Jul-23-21 01:53PM  
Jul-22-21 03:03PM  
02:36PM  
11:10AM  
06:31AM  
Jul-21-21 05:50PM  
01:43PM  
11:22AM  
Jul-20-21 04:01PM  
02:51PM  
Jul-19-21 02:01PM  
08:50AM  
08:00AM  
06:17AM  
06:06AM  
Jul-17-21 06:01AM  
06:01AM  
Jul-16-21 01:37PM  
Jul-15-21 05:50PM  
04:05PM  
02:58PM  
Jul-14-21 01:49PM  
11:10AM  
Jul-13-21 06:05AM  
Jul-12-21 03:09PM  
07:30AM  
07:19AM  
Jul-10-21 08:01AM  
Jul-09-21 05:50PM  
02:22PM  
Jul-08-21 01:57PM  
Jul-07-21 01:46PM  
Jul-06-21 02:21PM  
Jul-05-21 01:08PM  
Jul-02-21 01:39PM  
Jul-01-21 03:24AM  
Jun-30-21 05:50PM  
02:39PM  
02:20PM  
Jun-29-21 07:08PM  
03:07PM  
Jun-28-21 04:09PM  
02:09PM  
09:48AM  
08:30AM  
Jun-26-21 02:38PM  
Jun-25-21 06:29AM  
Jun-24-21 05:50PM  
02:00PM  
11:54AM  
09:00AM  
Jun-23-21 01:48PM  
12:29PM  
08:40AM  
05:34AM  
Jun-22-21 01:52PM  
09:36AM  
Jun-21-21 05:31PM  
02:44PM  
08:58AM  
08:19AM  
08:00AM  
04:00AM  
Jun-18-21 02:04PM  
09:07AM  
Jun-17-21 05:50PM  
03:07PM  
01:52PM  
09:00AM  
Jun-16-21 01:48PM  
Jun-15-21 06:24PM  
03:20PM  
08:00AM  
Jun-14-21 02:36PM  
01:47PM  
10:09AM  
Jun-12-21 12:14PM  
10:00AM  
Jun-11-21 05:50PM  
01:57PM  
08:45AM  
Jun-10-21 05:00PM  
Jun-09-21 02:50PM  
Jun-08-21 02:03PM  
10:02AM  
06:15AM  
Jun-07-21 02:39PM  
01:45PM  
Jun-04-21 05:50PM  
03:00PM  
02:50PM  
02:30PM  
02:12PM  
09:00AM  
Jun-03-21 01:36PM  
Jun-02-21 02:15PM  
01:44AM  
Jun-01-21 02:57PM  
May-28-21 01:43PM  
May-27-21 02:10PM  
Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of human immunodeficiency virus (HIV) infection; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr; Tizona; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos; Janssen; Japan Tobacco, Inc.; Gadeta; Bristol-Myers Squibb Company; Merck; and Novo Nordisk A/S. The company was founded in 1987 and is headquartered in Foster City, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Mercier JohannaChief Commercial OfficerMay 04Sale66.0919,4961,288,5478,068May 05 05:02 PM
Whitley Richard JamesDirectorMay 03Option Exercise20.6420,282418,72251,404May 04 06:37 PM
Whitley Richard JamesDirectorMay 03Sale64.5720,2821,309,65531,122May 04 06:37 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselMar 11Sale63.361,48694,15329,166Mar 12 06:39 PM
Wilfong Diane E.SVP, Controller & CAOFeb 10Option Exercise0.00778017,606Feb 11 05:58 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 10Sale67.411,975133,13528,832Feb 11 05:56 PM
Wilfong Diane E.SVP, Controller & CAOFeb 06Option Exercise0.001,866017,361Feb 09 07:46 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 06Option Exercise0.002,728031,560Feb 09 07:44 PM
Dickinson Andrew DEVP, Chief Financial OfficerFeb 06Option Exercise0.001,818033,081Feb 09 07:41 PM
Pletcher Brett AEVP,Corp Affairs & Gen CounselFeb 01Sale65.979,711640,63328,832Feb 03 06:23 PM
Lofton Kevin EDirectorJan 22Option Exercise20.6420,282418,72274,203Jan 25 01:55 PM
Whitley Richard JamesDirectorOct 01Option Exercise0.001,434031,122Oct 05 07:09 PM
Parsey MerdadChief Medical OfficerAug 17Sale68.3218212,4340Aug 19 12:53 PM
Mercier JohannaChief Commercial OfficerJul 24Option Exercise0.007,50507,505Jul 28 06:47 PM